Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mario Lamping"'
Autor:
Damian T. Rieke, Till de Bortoli, Peter Horak, Mario Lamping, Manuela Benary, Ivan Jelas, Gina Rüter, Johannes Berger, Marit Zettwitz, Niklas Kagelmann, Andreas Kind, Falk Fabian, Dieter Beule, Hanno Glimm, Benedikt Brors, Albrecht Stenzinger, Stefan Fröhling, Ulrich Keilholz
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Structured and harmonized implementation of molecular tumor boards (MTB) for the clinical interpretation of molecular data presents a current challenge for precision oncology. Heterogeneity in the interpretation of molecular data
Externí odkaz:
https://doaj.org/article/a71d027ee7a141939a13080926536b92
Autor:
Fabian Frontzek, Annette M. Staiger, Myroslav Zapukhlyak, Wendan Xu, Irina Bonzheim, Vanessa Borgmann, Philip Sander, Maria Joao Baptista, Jan-Niklas Heming, Philipp Berning, Ramona Wullenkord, Tabea Erdmann, Mathias Lutz, Pia Veratti, Sophia Ehrenfeld, Kirsty Wienand, Heike Horn, John R. Goodlad, Matthew R. Wilson, Ioannis Anagnostopoulos, Mario Lamping, Eva Gonzalez-Barca, Fina Climent, Antonio Salar, Josep Castellvi, Pau Abrisqueta, Javier Menarguez, Teresa Aldamiz, Julia Richter, Wolfram Klapper, Alexandar Tzankov, Stefan Dirnhofer, Andreas Rosenwald, José Luis Mate, Gustavo Tapia, Peter Lenz, Cornelius Miething, Wolfgang Hartmann, Björn Chapuy, Falko Fend, German Ott, José-Tomas Navarro, Michael Grau, Georg Lenz
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Plasmablastic lymphoma (PBL) is an aggressive lymphoma subtype characterized by poor prognosis but the molecular knowledge of the disease is limited. Here, the authors perform whole exome sequencing and copy number determination of primary samples hi
Externí odkaz:
https://doaj.org/article/6d054d5ed82e4409b9428afb7baa476b
Autor:
Jurica Ševa, David Luis Wiegandt, Julian Götze, Mario Lamping, Damian Rieke, Reinhold Schäfer, Patrick Jähnichen, Madeleine Kittner, Steffen Pallarz, Johannes Starlinger, Ulrich Keilholz, Ulf Leser
Publikováno v:
BMC Bioinformatics, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Diagnosis and treatment decisions in cancer increasingly depend on a detailed analysis of the mutational status of a patient’s genome. This analysis relies on previously published information regarding the association of variati
Externí odkaz:
https://doaj.org/article/be2c7873700441b5910564fc13426d83
Autor:
Kilannin Krysiak, Arpad M Danos, Jason Saliba, Joshua F McMichael, Adam C Coffman, Susanna Kiwala, Erica K Barnell, Lana Sheta, Cameron J Grisdale, Lynzey Kujan, Shahil Pema, Jake Lever, Sarah Ridd, Nicholas C Spies, Veronica Andric, Andreea Chiorean, Damian T Rieke, Kaitlin A Clark, Caralyn Reisle, Ajay C Venigalla, Mark Evans, Payal Jani, Hideaki Takahashi, Avila Suda, Peter Horak, Deborah I Ritter, Xin Zhou, Benjamin J Ainscough, Sean Delong, Chimene Kesserwan, Mario Lamping, Haolin Shen, Alex R Marr, My H Hoang, Kartik Singhal, Mariam Khanfar, Brian V Li, Wan-Hsin Lin, Panieh Terraf, Laura B Corson, Yasser Salama, Katie M Campbell, Kirsten M Farncombe, Jianling Ji, Xiaonan Zhao, Xinjie Xu, Rashmi Kanagal-Shamanna, Ian King, Kelsy C Cotto, Zachary L Skidmore, Jason R Walker, Jinghui Zhang, Aleksandar Milosavljevic, Ronak Y Patel, Rachel H Giles, Raymond H Kim, Lynn M Schriml, Elaine R Mardis, Steven J M Jones, Gordana Raca, Shruti Rao, Subha Madhavan, Alex H Wagner, Malachi Griffith, Obi L Griffith
Publikováno v:
Nucleic Acids Research. 51:D1230-D1241
CIViC (Clinical Interpretation of Variants in Cancer; civicdb.org) is a crowd-sourced, public domain knowledgebase composed of literature-derived evidence characterizing the clinical utility of cancer variants. As clinical sequencing becomes more pre
Autor:
Kilannin Krysiak, Arpad M. Danos, Susanna Kiwala, Joshua F. McMichael, Adam C. Coffman, Erica K. Barnell, Lana Sheta, Jason Saliba, Cameron J. Grisdale, Lynzey Kujan, Shahil Pema, Jake Lever, Nicholas C. Spies, Andreea Chiorean, Damian T. Rieke, Kaitlin A. Clark, Payal Jani, Hideaki Takahashi, Peter Horak, Deborah I. Ritter, Xin Zhou, Benjamin J. Ainscough, Sean Delong, Mario Lamping, Alex R. Marr, Brian V. Li, Wan-Hsin Lin, Panieh Terraf, Yasser Salama, Katie M. Campbell, Kirsten M. Farncombe, Jianling Ji, Xiaonan Zhao, Xinjie Xu, Rashmi Kanagal-Shamanna, Kelsy C. Cotto, Zachary L. Skidmore, Jason R. Walker, Jinghui Zhang, Aleksandar Milosavljevic, Ronak Y. Patel, Rachel H. Giles, Raymond H. Kim, Lynn M. Schriml, Elaine R. Mardis, Steven J. M. Jones, Gordana Raca, Shruti Rao, Subha Madhavan, Alex H. Wagner, Obi L. Griffith, Malachi Griffith
Publikováno v:
Nat Cancer
As guidelines, therapies, and literature on cancer variants expand, the lack of consensus variant interpretations impedes clinical applications. CIViC is a public domain, crowd-sourced, and adaptable knowledgebase of evidence for the Clinical Interpr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed50e6a9356f3f2f4e3e63d326c2871
https://eprints.gla.ac.uk/279775/1/279775.pdf
https://eprints.gla.ac.uk/279775/1/279775.pdf
Autor:
Serge Leyvraz, Frank Konietschke, Caroline Peuker, Moritz Schütte, Thomas Kessler, Sebastian Ochsenreither, Marc Ditzhaus, Erin D. Sprünken, Gina Dörpholz, Mario Lamping, Damian T. Rieke, Konrad Klinghammer, Susen Burock, Claas Ulrich, Gabriela Poch, Reinhold Schäfer, Frederick Klauschen, Antonia Joussen, Marie-Laure Yaspo, Ulrich Keilholz
Publikováno v:
European journal of cancer (Oxford, England : 1990). 169
Targeted therapies for metastatic uveal melanoma have shown limited benefit in biomarker-unselected populations. The Treat20 Plus study prospectively evaluated the feasibility of a precision oncology strategy in routine clinical practice.Fresh biopsi
Autor:
Christophe Le Tourneau, Mark E. Burkard, Serge Leyvraz, Marissa Schuh, Damian T. Rieke, Ulrich Keilholz, Mario Lamping, Neus Baste, Klaus H. Metzeler
Publikováno v:
JCO Precision Oncology. :1-14
Purpose Precision oncology holds the promise of improving patient outcome. It is based on the idea that the testing of genomic biomarkers can lead to the recommendation of a treatment option tailored to the specific patient. To derive treatment recom
Autor:
Johannes Starlinger, U. Keilholz, Mario Lamping, Julian Götze, Till de Bortoli, Bariya Bajwa, Gina Rüter, Mario Sänger, Madeleine Kittner, Ivan Jelas, Jurica Ševa, Oliver Kohlbacher, Marit Zettwitz, Maryam Habibi, Nisar P. Malek, Damian T. Rieke, Leonie Ostermann, Ulf Leser, Hanjo Hautow
Publikováno v:
JAMIA Open
Objective We present the Berlin-Tübingen-Oncology corpus (BRONCO), a large and freely available corpus of shuffled sentences from German oncological discharge summaries annotated with diagnosis, treatments, medications, and further attributes includ
Autor:
Michael Grau, Kirsty Wienand, Pia Veratti, Gustavo Tapia, Tabea Erdmann, Eva González-Barca, Falko Fend, Jan-Niklas Heming, Björn Chapuy, Irina Bonzheim, Sophia Ehrenfeld, Alexandar Tzankov, Javier Menárguez, Mathias Lutz, Philip Sander, Matthew R. Wilson, José-Tomás Navarro, Julia Richter, Wolfram Klapper, Stefan Dirnhofer, Cornelius Miething, Pau Abrisqueta, Andreas Rosenwald, Fina Climent, Ioannis Anagnostopoulos, Mario Lamping, Wendan Xu, Annette M. Staiger, Georg Lenz, Myroslav Zapukhlyak, Philipp Berning, Vanessa Borgmann, Wolfgang Hartmann, Peter Lenz, Teresa Aldamiz, Fabian Frontzek, German Ott, Maria Joao Baptista, Josep Castellví, Antonio Salar, Jose Luis Mate, Heike Horn, John R. Goodlad, Ramona Wullenkord
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Nature Communications
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Scientia
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Universidad de Barcelona
Nature Communications
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Scientia
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Plasmablastic lymphoma (PBL) represents a rare and aggressive lymphoma subtype frequently associated with immunosuppression. Clinically, patients with PBL are characterized by poor outcome. The current understanding of the molecular pathogenesis is l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd88233e6b47877ca5d45e25f3a08e7
http://hdl.handle.net/2445/180256
http://hdl.handle.net/2445/180256
Autor:
C. Benedikt Westphalen, Anne Letsch, Theresia Pichler, Ute Goerling, Philipp J. Jost, Amy Rohrmoser, Mario Lamping, Kristina Riedmann, Volker Heinemann, Peter Herschbach, Ulrich Keilholz
Publikováno v:
Supportive Care in Cancer
Purpose Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9cfa3c3a9a66804f6ac188ecf570d61
https://mediatum.ub.tum.de/doc/1586277/document.pdf
https://mediatum.ub.tum.de/doc/1586277/document.pdf